Table 12.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2002 to 2006

Recipients with Lung Transplants

  No Steroids Used for Maintenance Steroids Used for Maintenance
N % N %
Functioning Graft with Immunosuppression Info at Discharge 159 100.0% 5,447 100.0%
Induction Drugs        
Atgam/NRATG/NRATS 13 8.2% 281 5.2%
OKT3     48 0.9%
Thymoglobulin 8 5.0% 221 4.1%
Zenapax 28 17.6% 791 14.5%
Simulect 31 19.5% 1,100 20.2%
Campath 12 7.5% 194 3.6%
Rituximab     4 0.1%
No Induction Drug Reported 69 43.4% 2,844 52.2%


Source: OPTN/SRTR Data as of May 1, 2007.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.